earnings
confidence high
sentiment negative
materiality 0.75
Repligen Q1 revenue $182.7M, down 12% YoY; cuts full-year guidance on macro headwinds
REPLIGEN CORP
2023-Q1 EPS reported
$0.51
revenue$182,660,000
- GAAP EPS $0.51 (down 37% YoY); adjusted EPS $0.64 (down 30% YoY); gross margin 55.2% (down 520 bps).
- Total revenue guidance cut to $720-760M (prev $760-800M); base business growth lowered to 4-8% (prev 11-15%).
- Completed acquisition of single-use bag maker FlexBiosys in April; adds to Fluid Management portfolio.
- Sees softness in AsiaPac (especially China) and slower order recovery; COVID-related revenue expected $30-40M.